Polyunsaturated Fatty Acids Market Size, Share, Opportunities, And Trends By Application (Food, Nutraceutical, Pharmaceutical, Feed Applications), By Type (Omega-3, Omega-6), By Form (Tablet, Liquid, Softgel, Powder), And By Geography - Forecasts From 2024 To 2029

  • Published : Mar 2024
  • Report Code : KSI061616421
  • Pages : 143

The polyunsaturated fatty acids market is projected to rise at a compound annual growth rate (CAGR) of 8.13% to reach a market valuation of US$18.527 billion by 2029, from US$10.717 billion in 2022.

Polyunsaturated fats encompass essential fatty acids categorized as omega-3 and omega-6 fats, pivotal for supporting brain function and cellular growth. The Polyunsaturated Fatty Acids Market is bolstered by several driving factors, including increasing awareness of health benefits, surging demand for functional foods and beverages, and innovations in delivery formats and applications.

Growing prevalence of cardiovascular diseases propels the market.

One significant driver stems from the global demographic shift towards an aging population, as older adults are more prone to chronic ailments. This trend expands the market for products targeting cognitive and cardiovascular health, areas where PUFAs have demonstrated efficacy. The population aged 65 and over is projected to rise across OECD member countries, from 17.3% in 2019 to 26.7% by 2050, further fueling market growth. Moreover, the incidence of chronic diseases such as heart disease, stroke, and diabetes, are escalating worldwide, often attributed to inadequate PUFA intake and poor dietary choices. Cardiovascular diseases, accounting for a significant portion of non-communicable disease (NCD) deaths annually, 17.9 million people annually, underscore the necessity for PUFAs. According to the World Health Organization (WHO), cardiovascular diseases claim the most lives, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million), emphasizing the critical role of PUFAs in combating these health challenges.

The market is projected to grow in the North American region.

The polyunsaturated fatty acids market is projected to rise at a significant growth rate. In addition, the increasing market developments including product launches, collaborations, agreements, acquisitions, and other related factors. The main factors driving the market growth are the increasing incidence of cardiovascular disease and growing public awareness of the benefits of PUFAs in the treatment of chronic illnesses. Thus, it is anticipated that the growing prevalence of cardiovascular disease will support the polyunsaturated fatty acid market growth.

Key Players:

  • Healthyr-U is committed to assisting in the achievement of optimal health and provides a comprehensive range of nutrition and wellness services, from vitamins and immunity boosters to skin and hair therapy, gut health, and sleep wellness. Every product is carefully designed, researched, and formulated to satisfy the needs and expectations.
  • Cayman Chemical Company provides the tools scientists need to improve animal and human health around the globe. They provide contract services for custom chemical synthesis/analysis, assay development/screening, and drug discovery, in addition to manufacturing high-quality biochemicals, assay kits, antibodies, and recombinant proteins.
  • Merck KGaA is a worldwide science and technology company. Best-in-class products for pharmaceutical development and manufacturing, one of the widest portfolios in the industry for scientists, and a fully integrated service organization to support CDMO and contract testing across conventional and innovative modalities are all offered by them.

Segmentation:

  • By Application:
    • Food
    • Nutraceutical
    • Pharmaceutical
    • Feed Applications
  • By Type:
    • Omega-3
    • Omega-6
  • By Form:
    • Tablet
    • Liquid
    • Softgel
    • Powder
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Russia-Ukraine War Impact Analysis

5. POLYUNSATURATED FATTY ACIDS MARKET BY APPLICATION

5.1. Introduction 

5.2. Food

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Nutraceutical

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

5.4. Pharmaceutical

5.4.1. Market Trends and Opportunities

5.4.2. Growth Prospects

5.4.3. Geographic Lucrativeness

5.5. Feed Applications

5.5.1. Market Trends and Opportunities

5.5.2. Growth Prospects

5.5.3. Geographic Lucrativeness

6. POLYUNSATURATED FATTY ACIDS MARKET BY TYPE

6.1. Introduction 

6.2. Omega-3

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Omega-6

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

7. POLYUNSATURATED FATTY ACIDS MARKET BY FORM

7.1. Introduction 

7.2. Tablet

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.2.3. Geographic Lucrativeness

7.3. Liquid

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.3.3. Geographic Lucrativeness

7.4. Softgel

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

7.4.3. Geographic Lucrativeness

7.5. Powder

7.5.1. Market Trends and Opportunities

7.5.2. Growth Prospects

7.5.3. Geographic Lucrativeness

8. POLYUNSATURATED FATTY ACIDS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Application

8.2.2. By Type

8.2.3. By Form

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Application

8.3.2. By Type

8.3.3. By Form

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Application

8.4.2. By Type

8.4.3. By Form

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Spain

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Others

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Application

8.5.2. By Type

8.5.3. By Form

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Israel

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.5.4.4. Others

8.5.4.4.1. Market Trends and Opportunities

8.5.4.4.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Application

8.6.2. By Type

8.6.3. By Form

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Trends and Opportunities

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Trends and Opportunities

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Trends and Opportunities

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Trends and Opportunities

8.6.4.4.2. Growth Prospects

8.6.4.5. Indonesia

8.6.4.5.1. Market Trends and Opportunities

8.6.4.5.2. Growth Prospects

8.6.4.6. Thailand

8.6.4.6.1. Market Trends and Opportunities

8.6.4.6.2. Growth Prospects

8.6.4.7. Others

8.6.4.7.1. Market Trends and Opportunities

8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Healthyr-U (Zuventus Healthcare Limited)

10.2. Matreya LLC (Cayman Chemical Company)

10.3. Merck KGaA, Darmstadt

10.4. RawRX

10.5. Kemin Industries, Inc.

10.6. Mad Barn Inc.

10.7. Carlson Labs

10.8. Momentous

10.9. Marnys (Martínez Nieto S.A. Laboratories)

10.10. Natural Organics Inc.

10.11. Epax

10.12. BASF

10.13. DSM

10.14. Soultex

10.15. Vitabiotics


Healthyr-U (Zuventus Healthcare Limited)

Matreya LLC (Cayman Chemical Company)

Merck KGaA, Darmstadt

RawRX

Kemin Industries, Inc.

Mad Barn Inc.

Carlson Labs

Momentous

Marnys (Martínez Nieto S.A. Laboratories)

Natural Organics Inc.

Epax

BASF

DSM

Soultex

Vitabiotics